SHRX — Sharp Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- CA$15.81m
- CA$15.70m
- 35
- 15
- 74
- 36
Annual balance sheet for Sharp Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 0.08 | 0.15 | 0.396 |
| Net Total Receivables | — | 0.005 | 0 |
| Total Other Current Assets | |||
| Total Current Assets | 0.08 | 0.17 | 0.396 |
| Total Assets | 0.08 | 0.17 | 0.396 |
| Payable / Accrued | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.093 | 0.046 | 0.025 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 0.093 | 0.046 | 0.025 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | -0.014 | 0.123 | 0.371 |
| Total Liabilities & Shareholders' Equity | 0.08 | 0.17 | 0.396 |
| Total Common Shares Outstanding |